(Q45171136)

English

Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty

scientific article published in June 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D W Sundlof

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

P Rerkpattanapitat

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

N Wongpraparut

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

P Pathi

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

M N Kotler

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

L E Jacobs

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

G S Ledley

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

S Yazdanfar

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1569-71, A7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Meeting highlights: 47th Annual Scientific Sessions of the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900151-4

7 January 2021

Identifiers

10.1016/S0002-9149(99)00151-4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45171136&oldid=2069019591"